The cancer center, part of Lehigh Valley Topper Cancer Institute, will offer advanced diagnostic, treatment and support services, including access to clinical trials. Lehigh Valley Topper Cancer Institute is one of only three cancer centers in the country participating in the Memorial Sloan Kettering Cancer Alliance, which provides patients with additional lifesaving care options close to home.
Michael Evans, MD, with LVPG Hematology Oncology, who helped establish the Cancer Center at LVH–Hazleton in 2014, says that patient volume has consistently grown over the years. “The need for these services has never been more clear,” he says.
He adds that people will have access to advanced treatment, such as precision stereotactic radiation therapy delivered with a state-of-the-art linear accelerator with CT simulator, as well as an expanded infusion suite and consultations with rotating cancer specialists.
“Providing advanced cancer services for our patients in the Northwest region under one roof has been a long-term goal for LVHN, and this new cancer center will bring us closer to fulfilling that mission,” says Suresh Nair, MD, Physician in Chief, Lehigh Valley Topper Cancer Institute.
The cancer center is projected to open in late 2023.